(Q33596048)

28 July 2017

title

Autonomous growth potential of leukemia blast cells is associated with poor prognosis in human acute leukemias (English)

1 reference

28 July 2017

1 reference

Ying Yan

1

1 reference

28 July 2017

Eric A Wieman

2

1 reference

28 July 2017

Xiuqin Guan

3

1 reference

28 July 2017

Ann A Jakubowski

4

1 reference

28 July 2017

Peter G Steinherz

5

1 reference

28 July 2017

Richard J O'Reilly

6

1 reference

28 July 2017

publication date

29 December 2009

1 reference

Journal of Hematology & Oncology

28 July 2017

published in

1 reference

28 July 2017

volume

2

1 reference

28 July 2017

page(s)

51

1 reference

Creative Commons Attribution 2.0 Generic

28 July 2017

copyright license

start time

1 December 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Contribution of bone microenvironment to leukemogenesis and leukemia progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

A robust xenotransplantation model for acute myeloid leukemia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

Acute promyelocytic leukemia: from highly fatal to highly curable

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

Acute myeloid leukemia and acute promyelocytic leukemia.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

Granulocyte-macrophage colony-stimulating factor as an autocrine survival factor for mature normal and malignant B lymphocytes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

Humanized model to study leukemic stem cells.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

Differentiation therapy of leukemia: 3 decades of development

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

Autocrine and/or paracrine growth of adult T-cell leukaemia tumour cells by interleukin 15.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

A novel predictive model of outcome in de novo AML based on S-phase activity and proliferative response of blast cells to haemopoietic growth factors.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

Multidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807866

Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia

30 October 2018

1 reference

12 December 2020

Childhood acute myeloid leukemia in mice with severe combined immunodeficiency

1 reference

12 December 2020

Growth pattern and clinical correlation of subcutaneously inoculated human primary acute leukemias in severe combined immunodeficiency mice

1 reference

12 December 2020

Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias

1 reference

12 December 2020

In vitro growth in acute myeloblastic leukaemia: relationship with other clinico-biological characteristics of the disease

1 reference

12 December 2020

Detection and clinical significance of human acute myeloid leukaemia progenitors capable of long-term proliferation in vitro

1 reference

12 December 2020

Identifiers

DOI

10.1186/1756-8722-2-51

1 reference

Dimensions Publication ID

28 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1756-8722-2-51

9 September 2019

1 reference

28 July 2017

1 reference